Concord Wealth Partners’s Canopy Growth CGC Stock Holding History

Concord Wealth Partners’s Portfolio CGC Stock Details CGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-23	Closed	-$2K	–	1293
2021 Q4	$2K	Buy	+23	New	+$2.73K	﹤0.01%	1105
2021 Q1	–	Sell	-2	Closed	–	–	1004
2020 Q4	$0	Buy	+2	New	+$456	﹤0.01%	685

Other funds holding CGC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CIM

Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Concord Wealth Partners's CGC Position: Q1 2022 in Review

Concord Wealth Partners sold out of Canopy Growth (CGC) in Q1 2022, closing a stake of 23 shares — an estimated $2K sold.

Concord Wealth Partners first reported a position in CGC in Q4 2020 and held it in 2 quarters. The position peaked at $2K in Q4 2021. 379 funds tracked by Wall St. Rank hold CGC as of Q1 2022.

Concord Wealth Partners reported no remaining Canopy Growth position as of Q1 2022 after selling out during the quarter.
Concord Wealth Partners sold 23 Canopy Growth shares in Q1 2022, an estimated $2K.
Concord Wealth Partners first reported a position in Canopy Growth in Q4 2020 and held it in 2 quarters.
Concord Wealth Partners's Canopy Growth position peaked at $2K in Q4 2021.
379 funds tracked by Wall St. Rank held Canopy Growth as of Q1 2022.

Based on Concord Wealth Partners's 13F filing for Q1 2022, filed 20 Apr 2022.